Fact CheckerSign in

NCT07776834Active, not recruiting

Generative AI-Supported Personalized Education Compared With Printed Material for Adults With Hypertension

The Effect of Generative Artificial Intelligence-Supported Personalized Education Compared With Printed Material on Hypertension Knowledge and Medication Adherence in Adults With Hypertension

Source: ClinicalTrials.gov · Last updated 20 Aug 2026

Brief summary (registry, in English)

This study evaluates whether generative artificial intelligence-supported personalized education can improve hypertension knowledge and medication adherence in adults with hypertension compared with standard printed educational material. A total of 88 adults with hypertension are included in the study. Participants are assigned to either an intervention group or a control group. The control group receives a printed hypertension education booklet. The intervention group receives personalized educational content prepared using generative artificial intelligence based on individual characteristics and needs, together with weekly WhatsApp or SMS messages, voice messages, and brief telephone follow-up. The intervention lasts four weeks, and final assessments are performed in the fifth week. Hypertension knowledge, medication adherence self-efficacy, and blood pressure are assessed before and after the intervention. It is expected that personalized education will improve hypertension knowledge and medication adherence compared with printed education.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
88 (actual)
First submitted
18 Aug 2026
Start date
1 Jun 2026
Primary completion date
20 Dec 2026
Lead sponsor
Akdeniz University
NCT number
NCT07776834

What you commit to

  • Study type: Interventional
  • Participants enrolled: 88
  • From 1 Jun 2026 to the primary completion date, 20 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Withdrawal from the study after enrollment
  • Inability to be reached by telephone during the follow-up period

Who the study is looking for

  • Voluntary agreement to participate in the study
  • Diagnosis of hypertension
  • Use of antihypertensive medication for at least 6 months
  • Medication adherence self-efficacy score of 26 or lower
  • Age 18 years or older
  • Ability to read and write in Turkish
  • General health status adequate for communication
  • Ability to read SMS messages and use WhatsApp

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Akdeniz University Hospital
Coordinator of this site? Confirm its status
AntalyaTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.